Compounding Pharmacy IQ Center presents you with an ever changing and complex landscape of vendors, features, opportunities and challenges. With the Compounding Pharmacy IQ Center from Ophthalmology Management our editors hand select and present you with the most valuable white papers, cases studies and executive briefs to help you stay informed with meaningful content and make smarter decisions for your organization.
Drug Quality and Security Act Addresses Compounding Pharmacies One year after the deadly NECC fungal meningitis outbreak, the government has taken action by signing the Drug Quality and Security Act (DQSA). The DQSA has been up against plenty of scrutiny, declaring it overrides stricter states laws. This article will outline and review the DQSA's mission and how compounders are prepping for the changes. Read More
How to Choose a Compounding Pharmacy Carefully selecting a compounding pharmacy is more important than ever in the wake of the New England Compounding Center outbreak. Luckily the Pharmacy Compounding Accreditation Board provides certification for any pharmacy wishing to become accredited. Of the compounding pharmacies that have had incidents with tainted products, none were accredited by the PCAB. Read on to learn how to select a compounding pharmacy and why PCAB accreditation is important in the decision making process. Read More
Compound Interest: What Do You Know About Off-label Avastin Preparation A few years back contaminated Avastin injections caused endophthalmitis in around a dozen patients. In the wake of the outbreaks, surgeons who prescribe Avastin off-label are double-checking their compounding pharmacies quality assurance policies. Read on to learn the highlights on the legal and regulatory framework in which compounding pharmacies to business. Read More
AMD Update is a monthly e-newsletter dedicated to bringing to the ophthalmologist the latest and most useful clinical information and literature reviews on the management of AMD in a quick, easy to review format